LIPO-NEX
Shop LIPO-NEX on KimeraChems · code GUIDE (10% off)Definition
LIPO-NEX is a multi-component metabolic and lipotropic formulation developed for laboratory and analytical research applications. The formulation combines fatty-acid transport support (L-Carnitine), choline and inositol cofactors, an ATP-based energy substrate, a low-dose adrenergic modulator (Yohimbine HCl), and methylcobalamin (Vitamin B12). It is commonly explored in research models examining lipid utilization, mitochondrial function, sympathetic signaling, and cellular energy metabolism. The solution is prepared in sterile water with benzyl alcohol as a preservative. LIPO-NEX is not approved for human or veterinary use and is supplied strictly for laboratory and analytical research purposes.
Available Formats
- L-Carnitine: 400 mg
- Choline bitartrate: 50 mg
- Inositol: 50 mg
- ATP: 50 mg
- Yohimbine HCl: 2 mg
- Vitamin B12 (Methylcobalamin): 1 mg
Mechanism of Action
LIPO-NEX is evaluated as a combined formulation rather than a single active compound. Each component contributes to research-relevant biochemical pathways: The combined formulation is explored in research involving lipid utilization, mitochondrial energy metabolism, adrenergic signaling, and cofactor-supported metabolic-pathway integration.
- L-Carnitine: Studied for its role in transporting long-chain fatty acids into mitochondria and supporting β-oxidation-related energy metabolism
- Choline bitartrate: Investigated as a choline source supporting phospholipid synthesis and one-carbon-related metabolic pathways
- Inositol: Studied for its involvement in cellular signaling and membrane dynamics that intersect with metabolic regulation
- ATP: Used as an energy-substrate variable in select research contexts and generally evaluated as a metabolic input rather than a sustained direct energy source
- Yohimbine HCl: Studied as an α₂-adrenergic receptor antagonist in models evaluating sympathetic tone, catecholamine signaling, and lipolysis-related endpoints
- Vitamin B12 (Methylcobalamin): Investigated as a cofactor in energy metabolism and methylation-related pathways, often included to minimize cofactor-related confounding in multi-component research
Areas of Investigation
LIPO-NEX is commonly studied in
- Lipid-mobilization and fatty-acid-utilization models in which L-carnitine availability is a primary variable
- Mitochondrial-function and substrate-selection paradigms comparing fatty-acid and glucose utilization
- Adrenergic-signaling research involving sympathetic tone and α₂-adrenergic modulation
- Lipotropic and membrane-associated studies tracking choline and inositol metabolism
- Multi-component metabolic research in which structured comparator groups are used to evaluate pathway attribution
Safety Profile
Reported observations are component- and model-dependent and may include
- Stimulation-like effects in adrenergic-focused paradigms, including restlessness, wakefulness, or increased activity
- Tachycardia-like findings or blood-pressure-related changes in models sensitive to sympathetic activation
- Anxiety-like behaviors in paradigms where adrenergic tone is a primary variable
- Headache-like effects or gastrointestinal discomfort depending on study design and cumulative pathway activity
- Confounded outcomes when combined with additional adrenergic agents, caffeine comparators, or other lipolysis-promoting interventions
Interaction Notes
LIPO-NEX is often explored alongside interventions that overlap with its primary mechanistic pathways.
For educational purposes only. Not for human consumption.